Contact
Please use this form to send email to PR contact of this press release:
Pharmaceutical Entrepreneur Dr. Fred Sancilio Examines the Timeline to Approve a COVID-19 Drug
TO:
Dr. Frederick Sancilio, Ph.D.
Pharmaceutical Scientist/Entrepreneur